Treating patients with a statin drug early on may help heart attack survivors. The researchers based their findings on data from 1639 patients brought to the emergency room with symptoms of a heart attack who had not been receiving prior statin therapy. The data revealed that 1284 patients were treated with statins within 24 hours of admission, while the remaining 355 received statins at a later time. The results of the study, reported recently in the American Journal of Cardiology, found that patients in the early-statin group had a lower occurrence of death, stroke, repeat heart attack, and heart failure during their hospital stay, compared with patients who received statin therapy at a later time.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs